Antibacterial activity of five Peruvian medicinal plants against Pseudomonas aeruginosa  by Ulloa-Urizar, Gabriela et al.
HOSTED BY Contents lists available at ScienceDirect
Asian Pac J Trop Biomed 2015; 5(11): 928–931928Asian Paciﬁc Journal of Tropical Biomedicine
journal homepage: www.elsevier.com/locate/apjtbOriginal article http://dx.doi.org/10.1016/j.apjtb.2015.07.016*Corresponding author: Juana del Valle Mendoza, Universidad Peruana de
Ciencias Aplicadas, Avenue San Marcos cdra, Cedros de Villa, Lima, Peru.
Tel: +51 13133333 Annex 2704
Fax: +51 13496025
E-mail: jdelvall@upc.edu.pe
Peer review under responsibility of Hainan Medical University.
2221-1691/Copyright © 2015 Hainan Medical University. Production and hosting by Elsevier (Singapore) Pte Ltd. This is
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Antibacterial activity of five Peruvian medicinal plants against Pseudomonas
aeruginosaGabriela Ulloa-Urizar1,2, Miguel Angel Aguilar-Luis1, Marı´a del Carmen De Lama-Odrı´a1,
2 1,3*Jose´ Camarena-Lizarzaburu , Juana del Valle Mendoza
1Centro de Investigacio´n de la Facultad de Ciencias de la Salud, Universidad Peruana de Ciencias Aplicadas-UPC,
Avenue San Marcos cdra, Cedros de Villa, Lima, Peru
2Facultad de Ciencias Biolo´gicas, Universidad Nacional Mayor de San Marcos (UNMSM), Avda. Venezuela s/n, Lima 1, Peru
3Instituto de Investigacio´n Nutricional, Avenue La Molina 1885, Lima 12, PeruARTICLE INFO
Article history:
Received 22 Jun 2015
Received in revised form 27 Jun,
2nd revised form 1 Jul, 3rd revised
form 2 Jul 2015
Accepted 25 Jul 2015









Objective: To evaluate the susceptibility of Pseudomonas aeruginosa (P. aeruginosa)
in vitro to the ethanolic extracts obtained from ﬁve different Peruvian medicinal plants.
Methods: The plants were chopped and soaked in absolute ethanol (1:2, w/v). The
antibacterial activity of compounds against P. aeruginosa was evaluated using the cup-
plate agar diffusion method.
Results: The extracts from Maytenus macrocarpa (“Chuchuhuasi”), Dracontium lor-
etense Krause (“Jergon Sacha”), Tabebuia impetiginosa (“Tahuari”), Eucalyptus
camaldulensis Dehn (eucalyptus), Uncaria tomentosa (“Uña de gato”) exhibited favor-
able antibacterial activity against P. aeruginosa. The inhibitory effect of the extracts on
the strains of P. aeruginosa tested demonstrated that Tabebuia impetiginosa and May-
tenus macrocarpa possess higher antibacterial activity.
Conclusions: The results of the present study scientiﬁcally validate the inhibitory ca-
pacity of the ﬁve medicinal plants attributed by their common use in folk medicine and
contribute towards the development of new treatment options based on natural products.1. Introduction
In 2014, the World Health Organization released its ﬁrst
report on surveillance of antimicrobial resistance, revealing that
this is an increasing global threat and putting our capacity to
treat common nosocomial or community-acquired infection at
risk [1].
This growing problem was characterized by the infectious
diseases caused by multidrug-resistant Gram-negative bacteria
that challenge the public health policies worldwide at the point
of being known as the ESKAPE pathogens [Enterococcusfaecium, Staphylococcus aureus, Klebsiella pneumoniae, Aci-
netobacter baumannii, Pseudomonas aeruginosa
(P. aeruginosa) and Enterobacter spp.]. This term represents
their escape from the effects of the antibacterial agents or the
nonexistence of newer and more effective antibiotics [2].
P. aeruginosa is the most important toxigenic pathogen
within the genus Pseudomonas because of the quantity and types
of invasive infections it produces, as well as the noteworthy
morbidity and mortality associated [3]. This Gram-negative
bacterium has the ability to survive in adverse environments
and develop multiple antibiotic resistance mechanisms. Among
them, the most representative are the expression of
chromosomal-encoded AmpC b-lactamase, the reduction of
porin channels, the production of extended-spectrum b-lacta-
mase and the mutation of topoisomerase II and IV [4]. It must be
considered that several resistant mechanisms can coexist in one
strain and just one of them can be effective against numerous
antimicrobials [5].an open access article under the CC BY-NC-ND
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enhancement of the mortality rate of patients infected with this
pathogen [6]. Furthermore, this rate is higher among patients
infected with resistant strains and received inappropriate initial
empirical treatment [4]. Additionally, the rising indiscriminate
use of antimicrobials in health centers or by people who
practice self-medication could lead susceptible patients to get
infected by multidrug-resistant microorganisms [7,8]. The
emergence of antibiotic resistance and related toxicity issues
limit the use of these drugs, and generate a renaissance in
phytotherapy research [9]. To address this challenge, there is
growing interest in identifying and evaluating antimicrobial
compounds in extracts of medicinal plants as a new source of
drugs and alternative treatment approach [10].
Of all the regions in the world with a diverse ﬂora that can
naturally provide medicinal plants, Peru is a privileged one. It
possesses approximately 20000 plant species, which is equiva-
lent to 8% of the total number of plants in the world. Most of
them are native plants or grow in the Peruvian Amazon.
Nevertheless, probably less than 1% of the species have been
studied to determine their phytochemicals with potential me-
dicinal value [11,12].
The aim of present study was to evaluate the antibacterial
capacity of ﬁve traditionally used Peruvian plants against
P. aeruginosa in order to validate scientiﬁcally the inhibitory
activity attributed by their popular use and to propose new
sources of antimicrobial agents.
2. Materials and methods
2.1. Collection of plant materials
The plants Maytenus macrocarpa (M. macrocarpa) (com-
mon name: “Chuchuhuasi”), Dracontium loretense Krause
(D. loretense) (common name: “Jergon Sacha”), Tabebuia
impetiginosa (T. impetiginosa) (common name: “Tahuari”),
Eucalyptus camaldulensis Dehn (E. camaldulensis) (common
name: eucalyptus), Uncaria tomentosa (U. tomentosa) (common
name: “Uña de gato”) and Allium sativum (A. sativum) (common
name: garlic) used in this study were purchased from naturist
houses and six of them had sanitary registration.
2.2. Preparation of plant extracts
The plants were chopped and soaked in absolute ethanol (1:2,
w/v) under shade for 10 days at room temperature. The mixtures
were ﬁltered through a Whatman No. 4 ﬁlter paper and the ﬁl-
trates were evaporated at 50 C [13]. All extracts were stored at
4 C until use.
2.3. Bacterial test strain and growth conditions
For this study, a strain of P. aeruginosa (ATCC 55925) was
used and provided by the Microbiology Laboratory of the
Institute of Nutritional Research. The cultivation medium was
trypticase soy agar (trypticase soy broth) (Oxoid, Hampshire,
UK), supplemented with 10% deﬁbrinated sheep blood. Cultures
were grown aerobically for 24 h at 37 C. For antibacterial ac-
tivity assay, three or four isolated colonies were inoculated in
3 mL of brain heart infusion (BHI) broth and incubated without
agitation for 24 h at 37 C. The cultures were later diluted withfresh medium to approximate the density of 0.5 McFarland
standard, which represented an estimated concentration of
1.5 × 108 CFU/mL.
The McFarland standard was prepared by inoculating col-
onies of the bacterial test strain in sterile saline and adjusting the
cell density to the concentration speciﬁed before [14].
2.4. Antibacterial screening of the ethanolic extracts
2.4.1. Determination of antibacterial activity
To determine the antibacterial activity of studied extracts, the
cup-plate agar diffusion method was used [15]. BHI agar was
autoclaved for 15 min at 121 C and cooled to about 40–
42 C. The medium was then inoculated with 0.1 mL of the
prepared bacterial suspension, mixed gently and ﬁnally poured
into sterile Petri dishes. These agar plates were incubated
under sterile conditions for 8 h at room temperature. Three
wells per plate of 6 mm in diameter and 4 mm in depth were
made with the help of a sterile cork borer, preserving a
distance of 3 cm between them. The wells were ﬁlled with
100 mL of the corresponding ethanolic extract. The extract
from A. sativum (control of the extraction process) and
ciproﬂoxacin (32 g/mL) (commercial control) were used as
positive controls [8,16]. The Petri dishes were incubated under
the same growth conditions as mentioned above. At the end of
the period, the inhibition zones formed were measured in
millimeters using the vernier. The inhibition zones less than
12 mm in diameter were not considered for the antibacterial
activity analysis. For each extract, 12 replicates were assayed.
2.4.2. Determination of minimum inhibitory
concentration (MIC), minimum bactericidal
concentration (MBC) and minimum bacteriostatic
concentration (MBSC)
The MIC was determined using the microdilution method as
described by Jayaraman et al. [17] and Clinical and Laboratory
Standards Institute [18]. Serial two-fold dilutions of all the ex-
tracts were prepared with sterile saline in a 96-well microtiter
plate, obtaining a concentration range from 100 to 1.56 mg/mL.
Then, 5 mL of P. aeruginosa suspension (optical density at
550 nm = 0.6) were added to the wells containing the dilutions.
Each dose was assayed in quadruplicate. Uninoculated wells
containing sterile saline or saline and extract were used as
controls. After incubation for 24 h at 37 C, the samples were
observed. MIC was recorded as the lowest concentration of each
plant extract that inhibited the bacterial growth as detected by
the absence of visual turbidity.
To estimate the MBSC, an aliquot of each well that did not
show microbial growth in the prior tests was swabbed on the
entire surface of BHI agar plates and then incubated under the
growth conditions described before. Subsequently, the lowest
concentration of extract at which there was growth after sub-
culturing was considered as the MBSC. In contrast, the lowest
concentration that prevented the bacterial growth was registered
as MBC.
2.5. Statistical analysis
All data were analyzed using SPSS package (version 21.0.0)
for statistical analysis. For further inferential statistical analysis,
Levene's and Welch's tests were carried out.
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3.1. Antibacterial activity of the plant extracts
The ability of the selected ethanolic plant extracts to inhibit
P. aeruginosa growth was determined in this study. The results
revealed that 5 extracts exert antibacterial activity against this
microorganism. However, the extracts from M. macrocarpa and
T. impetiginosa exhibited higher inhibitory activity (P  0.05)
than the extracts from U. tomentosa, E. camaldulensis and
D. loretense. Maximum in vitro inhibition was scored by
M. macrocarpa, followed by T. impetiginosa, and U. tomentosa,
E. camaldulensis and D. loretense, which presented inhibition
zones of (22.47 ± 5.22) mm, (20.83 ± 3.03) mm, (19.32 ± 2.81)
mm, (18.20 ± 3.45) mm and (17.21 ± 2.76) mm, respectively. In
the case of the positive controls, ciproﬂoxacin and A. sativum
extract possess a clear anti-P. aeruginosa effect [16], which
presented inhibition zones of (25.89 ± 0.52) mm and
(22.56 ± 1.94) mm respectively.
3.2. Minimum inhibitory and bacteriostatic
concentration
MIC values ranged from 25 to 50 mg/mL. The ethanolic
extracts from T. impetiginosa displayed the minimum activity
against the evaluated bacteria strain with a MIC value of 50 mg/
mL. In the case of M. macrocarpa, D. loretense, U. tomentosa
and E. camaldulensis, the MIC value was 25 mg/mL, the same
as the one scored by A. sativum (positive control).
As for MBC and MBSC, M. macrocarpa, D. loretense and
T. impetiginosa showed a bacteriostatic action at a concentration
of 75 mg/mL, the same as MBSC of A. sativum (positive con-
trol). While for the case of U. tomentosa and E. camaldulensis,
MBSC is 100 and 50 mg/mL, respectively. In contrast, a
bactericidal action was observed at a concentration of 50 mg/mL
in the case of M. macrocarpa, D. loretense, T. impetiginosa and
U. tomentosa, which was the same as that of A. sativum (positive
control). While in the case of E. camaldulensis MBC is 25 mg/
mL.
4. Discussion
After the emergence of multi-drugs resistant pathogens, the
research for new remedy alternatives has led to the recognition
of the potential of medicinal plant extracts for treating the in-
fections associated to these type of microorganisms [19,20].
Moreover, there is a synergistic effect of antimicrobial plant
extracts with commonly used antibiotics; this effect has
become the foundation of a multitargeted approach used
against multi-drugs resistant bacteria [21–23].
Among the 6 major pathogens to which newer antimicrobials
are urgently required, P. aeruginosa is recognized as the etio-
logical agent of several community- and healthcare-associated
bacterial infections difﬁcult to eradicate [19]. This Gram-
negative bacterium has developed strains with remarkable sur-
vival, disseminations and resistant mechanisms to the ﬁrst
election antibiotics such as b-lactam because its outer membrane
functions as a barrier to several substances [24].
Therefore, this study aimed to determinate the antimicro-
bial activity of ﬁve endemic plants commonly used in tradi-
tional medicine in the Amazon and sierra regions of Peru inorder to validate scientiﬁcally their therapeutic properties [19].
The use of these plants in Peruvian Amazon folk medicinal
remedies for treating various health problems has already
been reported, and the plants have been tested as
antirheumatic, antidiarrheic, anticancer, antidiuretic and
tonic, antidiabetic and anti-inﬂammatory, and proposed as
novel therapy alternatives against this high-level resistant
bacterium [12].
By cup-plate agar diffusion method, the ethanolic extracts
from M. macrocarpa, D. loretense, T. impetiginosa,
E. camaldulensis and U. tomentosa showed anti-P. aeruginosa
activity, evidencing that ethanol is an efﬁcient organic solvent
to be used for the extraction of bioactive plant materials. Many
of the compounds with antibiotic efﬁcacy identiﬁed in plants
are saturated organic molecules or aromatic substances accu-
mulated as secondary metabolites in all plant cells to which
ethanol is a suitable solvent [25]. This information is important
because, according to Romero et al. [26], water is usually the
main solvent used by traditional healers to prepare plant
extracts, an election solvent that can affect the antibacterial
activity of the analyzed extracts. The microbial growth
inhibition capacity relies on the rich variety of
phytochemicals including ﬂavonoids, tannins, coumarins,
terpenoids, triterpenes, alkaloids and vegetable oils (such as
eucalyptol), and all compounds can be easily isolated by
ethanol, which is a suitable solvent for the extraction of
bioactive plant materials [27,28]. In fact, it is important to
emphasize that traditional healers can easily use alcohol or
aguardiente to prepare the macerations employed in
phytotherapy. Many of these remedies are used to treat
conditions that commonly result from bacterial infections of
the gastrointestinal and urinary tracts and in wound
infections [4].
Though all the ethanolic extracts possess similar antibacterial
efﬁcacy, our results demonstrated that MIC values are varied,
leading to conclude that the active principle exerting the bacte-
rial inhibition activity is different in each analyzed plant or that
the potent substance can be the same but the concentration
presented in each plant varies [11,16,29].
The results of the present study reinforce the importance of
the analyzed plants as a source of bioactive compounds for the
treatment of P. aeruginosa related infectious diseases. Similar
results were described by Mishra and Padhy [20], Yildirim
et al. [30], Radji et al. [9] and Zhang et al. [29] by using
extracts from Indian timber-yielding plants, Turkey medicinal
plants, green tea, and traditional Chinese medicinal herbs,
respectively. Nevertheless, their antibacterial ability was less
than that reported in our study.
Further chemical analysis of the aforementioned plant ex-
tracts should be performed to determinate their chemical
composition and identify the exact phytocompounds responsible
for antimicrobial activity. In addition, they should be subjected
to pharmacological evaluations with the aim of assessing their
in vivo efﬁcacy, toxicity, potential adverse effects, interactions
and contraindications.
The results proved that the extracts from M. macrocarpa,
D. loretense, T. impetiginosa, E. camaldulensis and
U. tomentosa exhibit a favorable antibacterial activity against
P. aeruginosa. These validate scientiﬁcally their inhibitory ca-
pacity attributed by their common use in folk medicine and
contribute towards the development of new treatment options
based on natural products.
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